PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Root extracts (whole and aqueous fraction) demonstrated analgesic properties in a rat model of chronic constriction injury (CCI)-induced neuropathic pain [PMID:37640257].
Hydroalcoholic extracts (specifically 80:20 ratio) were assessed for effectiveness in a rat model of streptozotocin-induced diabetic nephropathy [PMID:36975210].
Aqueous leaf extract displayed antiplasmodial activity in vivo in Plasmodium berghei-infected mice, prolonging survival [PMID:38161788].
Ethanolic extracts showed strong bactericidal effects against ampicillin and colistin-resistant Escherichia coli, Listeria monocytogenes, and Staphylococcus aureus [PMID:37750761].
Leaf extracts demonstrated significant in vitro antimycotic activity against Mucor circinelloides [PMID:35252443].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37861013 (2024) — Sida cordifolia L.: Ethnobotany, Phytochemistry, Phytonanotechnology, and Commercial Application. · Current pharmaceutical biotechnology
- 2.PMID: 36975210 (2023) — Evaluation of Sida cordifolia and Sida rhombifolia extracts in a rat model of streptozotocin-induced diabetic nephropathy. · Polimery w medycynie
- 3.PMID: 35961325 (2022) — Quality by design-based optimization of Soxhlet extraction and identification of ephedrine by a HPTLC method for Sida rhombifolia and Sida Cordifolia. · Biomedical chromatography : BMC
- 4.PMID: 37640257 (2024) — Sida cordifolia L. attenuates behavioral hypersensitivity by interfering with KIF17-NR2B signaling in rat model of neuropathic pain. · Journal of ethnopharmacology
- 5.PMID: 37750761